all report title image

PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VACCINE MARKET ANALYSIS

Porcine Reproductive and Respiratory Syndrome Vaccine Market, By Product Type (Modified Live Virus Vaccine, Inactivated Vaccine, and Subunit Vaccines), By Route of Administration (Intramuscular and Intradermal), By Virus Genotype (Type I and Type II), By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Global Industry Insights, Trends, Outlooks, and Opportunity Analysis, 2022-2028

  • To Be Published : Dec 2024
  • Code : CMI3285
  • Formats :
      Excel and PDF
  • Industry : Biotechnology

Leading Companies

Global Porcine Reproductive and Respiratory Syndrome Vaccine Market - Competitive Landscape

Key players operating in the porcine reproductive and respiratory syndrome vaccine market include Boehringer-Ingelheim GmbH, Zoetis, MSD Animal Health, Bioveta, Phibro Animal Health, Ceva , Ascent Corporation, Agrovet, Winsun Bio, Konipharm, Merck & Co., Inc., Elanco (Eli Lily and Company), and Ringpu (Tianjin) Bio-Pharmacy Co., Ltd.

Moreover, key players in the market are focused on developing new products in order to enhance their market share. For instance, in October 2019, Boehringer-Ingelheim launched Reprocyc ParvoFLEX, a subunit vaccine for the swine fetuses to protect them from the transplacental infections caused by porcine parovirus.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.